Google
×
AllImagesBooksNews Maps Videos Shopping
Search tools

Allogeneic stem cell transplantation in multiple myeloma: is there still a place?

Frontiers
The introduction of novel agents dramatically improved response and outcomes of multiple myeloma (MM) and led to a sharp decline in the use...
6 months ago

Efficient bone marrow irradiation and low uptake by non-haematological organs with an yttrium-90-anti-CD66 antibody prior to haematopoietic stem cell transplantation

Nature
We report the results of a Phase I radiation dose escalation study using an yttrium-90 (90Y) labelled anti-CD66 monoclonal antibody given...
5 months ago

Gösta Gahrton

Karolinska Institutet
Gösta Gahrton, Professor Emeritus/Emerita|Docent E-mail: gosta.gahrton@ki.se Telephone: +46852483310 Visiting address: Blickagången 16, 14151 Stockholm...
11 months ago

Bone marrow transplant

Mayo Clinic
Learn about this procedure that replaces unhealthy bone marrow with stem cells. Your own cells, donor cells or cells from umbilical cord...
8 months ago

A Comparison of Allografting with Autografting for Newly Diagnosed Myeloma

The New England Journal of Medicine
In this trial of the treatment of newly diagnosed multiple myeloma, we compared a protocol that entailed a hematopoietic stem-cell autograft followed by an...
78 months ago

The Role of Allogeneic Stem Cell Transplantation in Multiple Myeloma: A Systematic Review of the Literature

Cureus
Multiple myeloma (MM) is an indolent B-cell malignancy, where treatment is aimed at preventing organ dysfunction from light chain...
38 months ago

Long-term outcomes of allogeneic stem cell transplant in multiple myeloma | Blood Cancer Journal

Nature
Allogeneic stem cell transplant (allo SCT) for multiple myeloma (MM) is potentially curative in some, while toxic in many others.
15 months ago

First-Line Allogeneic Stem Cell Transplantation for Multiple Myeloma With Chromosome 13q Deletion

Hematology Advisor
A recent study examined treatment outcomes for patients with newly diagnosed multiple myeloma and chromosome 13q deletion (del13q).
62 months ago

Improved survival in multiple Myeloma patients undergoing autologous stem cell transplantation is entirely in the standard cytogenetic risk groups - Afram - 2021 - European Journal of Haematology

Wiley Online Library
Introduction Novel drugs and drug combinations have improved outcomes for multiple myeloma patients. However, subgroups of patients still...
46 months ago

Total marrow irradiation in hematopoietic stem cell transplantation for hematologic malignancies

Frontiers
Total body irradiation (TBI) has been an essential component of the conditioning regimen in hematopoietic cell transplantation for many...
19 months ago